The Cobactan family is made up of different formulations to treat a wide range of infections, caused by cefquinome sensitive pathogens, such as respiratory disease, mastitis, metritis, foot-rot and meningitis.
Pasteurella is the deadly factor in Bovine Pneumonia. It is reponsible for high mortality in cattle with Bovine Pneumonia. Fast, targeted Pasteurella treatment saves lives and reduces economic losses.
For the treatment of cattle affected by Bovine Respiratory Disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to cefquinome.
This website provides technical information on the Cobactan product range as well as background disease information.
Some sections of this website are only for registered health care professionals.
Login and registration.
Bovine Pneumonia or Respiratory Disease is a multifactorial syndrome. It is responsible for up to 75% of morbidity in feedlot cattle and is of of considerable economic significance in feedlots.
The disease is responsible for a high mortality rate and the condemnation of infected carcasses at slaughter.
Cefquinome, a 4th generation cephalosporin, is the active ingredient in the Cobactan range.
Cefquinome acts by inhibition of bacterial cell wall synthesis. Low concentrations ensure the destruction of targeted bacteria. Efficacy against major mastitis and Bovine Pneumonia pathogens has been clearly demonstrated.
Fast targeted treatment of Pasteurella saves lives and reduces economic losses in feedlots.